SEC Form 5 · accession 0000914190-16-000693
REGENERX BIOPHARMACEUTICALS INC · RGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J J Finkelstein
Officer — President and CEO · Director
Period of report
Dec 31, 2015
Accepted (ET)
Jul 15, 2016 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707511
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 25, 2015 | G | 100,000 | $0.00 | D | 1,277,638 | D |
Table II — derivative securities
No Table II lines on this filing.